These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 39012418)

  • 1. Interactions of antidepressants with concomitant medications-safety of complex therapies in multimorbidities.
    Dołoto A; Bąk E; Batóg G; Piątkowska-Chmiel I; Herbet M
    Pharmacol Rep; 2024 Aug; 76(4):714-739. PubMed ID: 39012418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants.
    Barkin RL; Schwer WA; Barkin SJ
    Am J Ther; 2000 May; 7(3):205-26. PubMed ID: 11317169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Depression in Patients with Concomitant Cardiac Disease.
    Teply RM; Packard KA; White ND; Hilleman DE; DiNicolantonio JJ
    Prog Cardiovasc Dis; 2016; 58(5):514-28. PubMed ID: 26562328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically significant drug interactions with newer antidepressants.
    Spina E; Trifirò G; Caraci F
    CNS Drugs; 2012 Jan; 26(1):39-67. PubMed ID: 22171584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.
    Rhee TG; Rosenheck RA
    J Affect Disord; 2019 Jun; 252():450-457. PubMed ID: 31004825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depression therapy for somatic diseases].
    Ivanov SV; Voronova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(5. Vyp. 2):106-112. PubMed ID: 34405665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-drug interactions between COVID-19 drug therapies and antidepressants.
    Davoutis E; Panou C; Stachika N; Dalla C; Kokras N
    Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):937-950. PubMed ID: 37934891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it safe to use antidepressants after a stroke?
    Rampello L; Battaglia G; Raffaele R; Vecchio I; Alvano A
    Expert Opin Drug Saf; 2005 Sep; 4(5):885-97. PubMed ID: 16111451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidepressants in epilepsy].
    Castaño-Monsalve B
    Rev Neurol; 2013 Aug; 57(3):117-22. PubMed ID: 23881616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data.
    Jeffery A; Bhanu C; Walters K; Wong IC; Osborn D; Hayes JF
    Br J Gen Pract; 2023 May; 73(730):e392-e398. PubMed ID: 37105749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for smoking cessation.
    Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant drugs and the emergence of suicidal tendencies.
    Teicher MH; Glod CA; Cole JO
    Drug Saf; 1993 Mar; 8(3):186-212. PubMed ID: 8452661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.
    Wolff J; Reißner P; Hefner G; Normann C; Kaier K; Binder H; Hiemke C; Toto S; Domschke K; Marschollek M; Klimke A
    PLoS One; 2021; 16(7):e0255192. PubMed ID: 34293068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting an antidepressant for use in a patient with epilepsy. Safety considerations.
    Curran S; de Pauw K
    Drug Saf; 1998 Feb; 18(2):125-33. PubMed ID: 9512919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.